Products for Research Use Only

Lucerastat

CAT: 1410-M11715-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M11715-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
A galactose analogue that is an UDP-glucose ceramide glucosyltransferase (UGCG/GCS) inhibitor (IC50=41.4 uM) .
CAS Number
141206-42-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
219.281
Molecular Formula
C10H21NO4
Notes
Research use only, not for human use.
Receptor
Other Targets

Chemical Information

Lucerastat

Lucerastat is under investigation in clinical trial NCT03425539 (Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease).

CAS Number141206-42-0
PubChem CID501391
IUPAC Name(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
Molecular FormulaC10H21NO4
Molecular Weight219.28
XLogP-0.6
Topological Polar Surface Area84.2
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Heavy Atom Count15
Formal Charge0
Complexity190
SMILES
CCCCN1C[C@@H]([C@H]([C@H]([C@H]1CO)O)O)O
InChI
InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9+,10-/m1/s1
InChIKey
UQRORFVVSGFNRO-XFWSIPNHSA-N
Chemical Structure
2D Structure
2D structure of Lucerastat
CAS: 141206-42-0
CID: 501391
Formula: C10H21NO4
MW: 219.28
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight219.28
XLogP3-0.6
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count5
Rotatable Bond Count4
Exact Mass219.14705815
Monoisotopic Mass219.14705815
Topological Polar Surface Area84.2 Ų
Heavy Atom Count15
Formal Charge0
Complexity190
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes